VRCA
NASDAQ · Pharmaceuticals
Verrica Pharmaceuticals Inc
$4.50
-0.35 (-7.22%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+113.1% upside
Low Target
$7.88
Average Target
$9.59
High Target
$13.36
Current Price
$4.50
Current
$4.50
$4.50
Target
$9.59
$9.59
$7.88
$9.59 avg
$13.36
Scenario Analysis
Bear Case
$7.88
75.1%
Low target
Base Case
$9.59
+113.1%
Avg target
Bull Case
$13.36
+196.9%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$9.82
-54.2% from high
52-Week Low
$3.28
+37.2% from low
Target vs 52W High
$9.59
-2.4% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |